Lansoprazole-Induced Improvement of Esophageal Submucosal Injury

The proton pumpvinhibitor, lansoprazole, is reported to have acid secretion inhibiting effect as well as anti-inflammatory effects such as inhibition of cytokine secretion from inflammatory cells. Clinically, excellent efficacy of lansoprazole is reported for not only gastric ulcer but also gastroesophageal reflux disease (GERD). Since GERD is categorized endoscopically into erosive esophagitis and non-erosive reflux disease, it is important to make accurate assessment of any improvement in the inflammatory process when using endoscopic ultrasonography (EUS) capable of visualizing the submucosal structure. We report here our experience in assessing the effect of treatment with lansoprazole on esophageal wall structure using EUS in patients with GERD. At baseline (before treatment), EUS showed abnormalities in the mucosa, submucosa and muscularis propria caused by inflammation, thickening of the entire esophageal wall and changes in the contractile properties of esophageal smooth muscles reflecting the effects of inflammation on the entire wall of the lower esophagus in reflux esophagitis regardless of whether it is erosive or endoscopically-negative. Treatment with lansoprazole resulted in normalization of esophageal wall structure and improvement of motility, suggesting that lansoprazole improves not only mucosal inflammation but also submucosal inflammation in GERD

Small GTP-binding protein Rho-mediated signaling promotes proliferation of rheumatoid synovial fibroblasts

Rho is a major small GTP-binding protein that is involved in the regulation of various cell functions, including proliferation and cell migration, through activation of multiple signaling molecules in various types of cells. We studied its roles in synovial fibroblasts (SFs) in patients with rheumatoid arthritis (RA) and clarified its relevance to RA synovitis, with the following results. 1)We found that the thrombin receptor was overexpressed on RA synovial fibroblasts (RA SFs) and that thrombin induced a marked proliferation and progression of the cell cycle to the S phase in these cells. 2)We also found that thrombin efficiently activated Rho. 3)Rho activation and proliferation and the progression of the cell cycle to the S phase were completely blocked by p115RGS (an N-terminal regulator of the G-protein signaling domain of p115RhoGEF) and by the C-terminal fragments of Gα13 (an inhibitor of the interaction of receptors with G13). 4)Thrombin induced the secretion of IL-6 by RA SFs, but this action was blocked by p115RGS or Gα13. Our findings show that the actions of thrombin on the proliferation of RA SFs, cell-cycle progression to the S phase, and IL-6 secretion were mainly mediated by the G13 and RhoGEF pathways. These results suggest that p115RGS and Gα13 could be potent inhibitors of such functions. A rational design of future therapeutic strategies for RA synovitis could perhaps include the exploitation of the Rho pathway to directly reduce the growth of synovial cells

Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial.

ObjectiveTo evaluate the efficacy of denosumab in suppressing joint destruction when added to conventional synthetic disease-modifying antirheumatic drug (csDMARD) therapy in patients with rheumatoid arthritis (RA).MethodsThis was a multi-centre, randomised, double-blind, parallel-group, placebo-controlled phase 3 study in Japan. Patients with RA aged ≥20 years receiving csDMARDs were randomly assigned (1:1:1) to denosumab 60 mg every 3 months (Q3M), denosumab 60 mg every 6 months (Q6M) or placebo. The change in the modified total Sharp score (mTSS) and effect on bone mineral density (BMD) at 12 months was evaluated.ResultsIn total, 654 patients received the trial drugs. Denosumab groups showed significantly less progression of joint destruction. The mean changes in the mTSS at 12 months were 1.49 (95% CI 0.99 to 1.99) in the placebo group, 0.99 (95% CI 0.49 to 1.49) in the Q6M group (p=0.0235) and 0.72 (95% CI 0.41 to 1.03) in the Q3M group (p=0.0055). The mean changes in bone erosion score were 0.98 (95% CI 0.65 to 1.31) in the placebo group, 0.51 (95% CI 0.22 to 0.80) in the Q6M group (p=0.0104) and 0.22 (95% CI 0.09 to 0.34) in the Q3M group (p=0.0001). No significant between-group difference was observed in the joint space narrowing score. The per cent change in lumbar spine (L1-L4) BMD in the placebo, Q6M and Q3M groups were -1.03%, 3.99% (p<0.0001) and 4.88% (p<0.0001). No major differences were observed among safety profiles.ConclusionsDenosumab inhibits the progression of joint destruction, increases BMD and is well tolerated in patients with RA taking csDMARD

Suppressive effect of azithromycin on Plasmodium berghei mosquito stage development and apicoplast replication

<p>Abstract</p> <p>Background</p> <p>Azithromycin (AZM) is a macrolide antibiotic that displays an excellent safety profile even in children and pregnant women and has been shown to have anti-malarial activity against blood stage <it>Plasmodium falciparum</it>. This study evaluated the transmission-blocking effect of AZM using a rodent malaria model.</p> <p>Methods</p> <p>AZM-treated mice infected with <it>Plasmodium berghei </it>were exposed to <it>Anopheles stephensi </it>mosquitoes, followed by the observation of parasite development at different phases in the mosquito, i.e., ookinetes in the midgut, oocysts on the midgut, and sporozoites in the midgut and salivary glands. Furthermore, to evaluate the effect on organelle replication of each stage, quantitative real-time PCR analysis was performed.</p> <p>Results</p> <p>The inhibitory effect of AZM was noticeable in both gametocyte-ookinete transformation in the midgut and sporozoite production in the oocyst, while the latter was most remarkable among all the developmental phases examined. Real-time PCR analysis revealed that AZM suppressed apicoplast replication at the period of sporozoite production in oocysts.</p> <p>Conclusions</p> <p>AZM inhibits parasite development in the mosquito stage, probably through the same mechanism as in the liver and blood stages. Such a multi-targeting anti-malarial, along with its safety, would be ideal for mass drug administration in malaria control programmes.</p

Significance of M. Polanyi\u27s Philosophy for Pedagogy

In Japan, several cognitive scientists have refered partly to M. Polanyi\u27s epistemology but most people have failed to grasp the significance of his philosophy. In this paper I will try to clearify the importance of his philosophy that has not been fully recognized in the science of education. Polanyi said that the fundamental of knowing is the skill of integrating details in meaning. This skill is tacit and bodily, so thinking that the knowledge is impartable is not right, and this is the same for linguistic knowledge. In communication with language, a linguistic sign doesn\u27t carry meaning in itself, but the recipient understands its meaning by applying his experience to the sign. So communication in language cannot succeed if the sender and recipient don\u27t possess the resemble use of language. And the bodily skill is fundamental to the use of language. If people want to acquire such skills, they must obey the authority of tradition, which has a risk of falling into indoctrination. Polanyi\u27s epistemology teaches us many important things for education. But the epistemological approach has a limit in that it cannot show the way to conquer the indoctrination taking root in the body. It is necessary to connect his epistemology with his ontology, which lets us find the special value of "knowing by indwelling"

Magnetocaloric and Magnetic Properties of Meta‐Magnetic Heusler Alloy Ni41Co9Mn31.5Ga18.5

Ni41Co9Mn31.5Ga18.5 is a magnetic Heusler alloy, which indicates metamagnetic transition at the reverse martensite transition. In this paper, caloric measurements were performed and discussed about magnetocaloric effect. We also performed magnetization measurements around Curie temperature TC in the martensite phase and analyzed by means of the spin fluctuation theory of itinerant electron magnetism. From the differential scanning calorimetry (DSC) measurements in zero fields, the value of the latent heat λ was obtained as 2.63 kJ/kg, and in magnetic fields the value was not changed. The entropy change ΔS was − 7.0 J/(kgK) in zero fields and gradually increases with increasing magnetic fields. The relative cooling power (RCP) was 104 J/kg at 2.0 T, which was comparable with In doped Ni41Co9Mn32Ga16In2 alloy